Telmisartan-HCT-Mepha 40/12.5 mg

Telmisartan-HCT-Mepha 40/12.5 mg is a medicine authorised by Swissmedic under authorisation number 65314. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 April 2015 and the authorisation is valid without a time limit. ATC code C09DA07 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 65314
  • ATC C09DA07
  • Synthetic medicines
Authorisation data
Authorisation number65314
NameTelmisartan-HCT-Mepha 40/12.5 mg
Full nameTelmisartan-HCT-Mepha 40/12.5 mg, Tabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DA07
First authorisation08 April 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Telmisartan-HCT-Mepha 40/12.5 mg, TablettenB08 April 2015
2Telmisartan-HCT-Mepha 80/12.5 mg, TablettenB08 April 2015
3Telmisartan-HCT-Mepha 80/25 mg, TablettenB08 April 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)C09DA0702.07.2.B
298Tablette(n)C09DA0702.07.2.B
328Tablette(n)C09DA0702.07.2.B
498Tablette(n)C09DA0702.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Telmisartan-HCT-Mepha 40/12.5 mg authorised in Switzerland?

Yes. Telmisartan-HCT-Mepha 40/12.5 mg is authorised by Swissmedic under authorisation number 65314, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Telmisartan-HCT-Mepha 40/12.5 mg have?

Telmisartan-HCT-Mepha 40/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Telmisartan-HCT-Mepha 40/12.5 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com